Top compounds associated with response to LYZL4


Feature Type Standardized
Nominal ANOVA
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.079 0.02
mRNA ZG-10 GDSC1000 pan-cancer AAC -0.1 0.02
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC -0.11 0.02
mRNA Doxorubicin gCSI pan-cancer AAC -0.11 0.02
mRNA MG-132 GDSC1000 pan-cancer AAC -0.11 0.02
mRNA Salubrinal GDSC1000 pan-cancer AAC 0.11 0.03
mRNA FH535 GDSC1000 pan-cancer AAC 0.074 0.03
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.17 0.03
mRNA CP724714 GDSC1000 pan-cancer AAC 0.072 0.03
mRNA Vorinostat gCSI pan-cancer AAC -0.11 0.03
Download CSV